2007
DOI: 10.1016/j.ejphar.2007.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
50
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 79 publications
(51 citation statements)
references
References 31 publications
1
50
0
Order By: Relevance
“…Accordingly, studies on the effect of L-Kyn are controversial. L-Kyn, apparently by elevating brain kynurenic acid levels, results in neuroprotection when administered before hypoxia/ischemia and N-methyl-daspartate lesions [40][41][42][43] ; conversely, and in agreement with our data, postischemic L-Kyn administration exacerbated acute neuronal damage after MCAO. 44 Therefore, direct actions of L-Kyn, without the involvement of its downstream metabolites, remained obscure.…”
Section: Discussionsupporting
confidence: 81%
“…Accordingly, studies on the effect of L-Kyn are controversial. L-Kyn, apparently by elevating brain kynurenic acid levels, results in neuroprotection when administered before hypoxia/ischemia and N-methyl-daspartate lesions [40][41][42][43] ; conversely, and in agreement with our data, postischemic L-Kyn administration exacerbated acute neuronal damage after MCAO. 44 Therefore, direct actions of L-Kyn, without the involvement of its downstream metabolites, remained obscure.…”
Section: Discussionsupporting
confidence: 81%
“…In the gerbil, the two-vessel occlusion model (occluding both common carotid arteries) is used because the posterior communicating arteries are not anatomically involved or are less anatomically involved, which results in better neuronal cell death in the hippocampus. A paucity of quantitative data on the infarct at 24 hr of reflow exists, because most of the reports are on 7 days of reflow and histological evaluation is made on the hippocampal CA1 sector (Gigler et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Most of the reports study effects after 7 days of reflow, and histological evaluation has been made on the hippocampal CA1 sector (Gigler et al, 2007). We chose to work on neurons because they are more sensitive to ischemia than glial cells (Plum, 1983).…”
mentioning
confidence: 99%
“…Therefore, elevation of brain KYNA level, either by administration of L-KYN or pharmacological manipulation of the availability of the kynurenine pathway enzymes, has become an attractive strategy to attenuate neuroinflammatory responses and to protect against glutamate induced excitotoxicity associated with ischemic brain injury (Tan et al, 2012;Vécsei et al, 2013). Accordingly, we and our collaborators achieved neuroprotection by the administration of L-KYN sulfate (L-KYNs) in experimental models of neurodegenerative diseases and ischemic stroke (Gigler et al, 2007;Németh et al, 2004;Vámos et al, 2009). In these studies, neuroprotection was achieved partly by the administration of 300 mg/bwkg LKYNs.…”
Section: Introductionmentioning
confidence: 99%